Biocep

Immunomagnetic cell isolation platform

placeYokneam Illit, Northern District, Israel calendar_todayFounded 2006 groups5 employees language biocep.com

Innovation

4 patent families (3 granted) — focus: Chemistry & metallurgy, Operations & transport; filing pace dormant. Cited 262 times.

YearFilings
20123
20131
20152
20162
20171
20181

Investor mix

4 investors on record; lead investors include General Electric.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%
Coming soon